Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic impact of PD-1 and PD-L1 expression in malignant pleural mesothelioma: an international multicenter study.
Brcic L, Klikovits T, Megyesfalvi Z, Mosleh B, Sinn K, Hritcu R, Laszlo V, Cufer T, Rozman A, Kern I, Mohorcic K, Jakopovic M, Samarzija M, Seiwerth S, Kolek V, Fischer O, Jakubec P, Škarda J, Gieszer B, Hegedus B, Fillinger J, Renyi-Vamos F, Buder A, Bilecz A, Berger W, Grusch M, Hoetzenecker K, Klepetko W, Hoda MA, Filipits M, Dome B. Brcic L, et al. Among authors: mosleh b. Transl Lung Cancer Res. 2021 Apr;10(4):1594-1607. doi: 10.21037/tlcr-20-1114. Transl Lung Cancer Res. 2021. PMID: 34012777 Free PMC article.
Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin.
Ries A, Flehberger D, Slany A, Pirker C, Mader JC, Mohr T, Schelch K, Sinn K, Mosleh B, Hoda MA, Dome B, Dolznig H, Krupitza G, Müllauer L, Gerner C, Berger W, Grusch M. Ries A, et al. Among authors: mosleh b. J Exp Clin Cancer Res. 2023 Jan 23;42(1):27. doi: 10.1186/s13046-022-02582-0. J Exp Clin Cancer Res. 2023. PMID: 36683050 Free PMC article.
Malignant pleural mesothelioma: recent developments.
Sinn K, Mosleh B, Hoda MA. Sinn K, et al. Among authors: mosleh b. Curr Opin Oncol. 2021 Jan;33(1):80-86. doi: 10.1097/CCO.0000000000000697. Curr Opin Oncol. 2021. PMID: 33186182 Review.
Clinical and prognostic implications of CD47 and PD-L1 expression in surgically resected small-cell lung cancer.
Lang C, Lantos A, Megyesfalvi Z, Egger F, Hoda MA, Mosleh B, Klikovits T, Oberndorfer F, Timelthaler G, Ferencz B, Fillinger J, Schwendenwein A, Querner AS, Boettiger K, Renyi-Vamos F, Hoetzenecker K, Laszlo V, Schelch K, Dome B. Lang C, et al. Among authors: mosleh b. ESMO Open. 2022 Dec;7(6):100631. doi: 10.1016/j.esmoop.2022.100631. Epub 2022 Nov 16. ESMO Open. 2022. PMID: 36399951 Free PMC article.
Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study.
Sinn K, Mosleh B, Steindl A, Zoechbauer-Mueller S, Dieckmann K, Widder J, Steiner E, Klepetko W, Hoetzenecker K, Laszlo V, Doeme B, Klikovits T, Hoda MA. Sinn K, et al. Among authors: mosleh b. ESMO Open. 2022 Apr;7(2):100466. doi: 10.1016/j.esmoop.2022.100466. Epub 2022 Apr 6. ESMO Open. 2022. PMID: 35397435 Free PMC article.
Corrigendum to 'Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study': [ESMO Open Volume 7, Issue 2, April 2022, 100466].
Sinn K, Mosleh B, Steindl A, Zoechbauer-Mueller S, Dieckmann K, Widder J, Steiner E, Klepetko W, Hoetzenecker K, Laszlo V, Dome B, Klikovits T, Hoda MA. Sinn K, et al. Among authors: mosleh b. ESMO Open. 2022 Jun;7(3):100523. doi: 10.1016/j.esmoop.2022.100523. Epub 2022 Jun 10. ESMO Open. 2022. PMID: 35696745 Free PMC article. No abstract available.
16 results